ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO0741

Single-Cell Metabolic Profiling of Kidney T Cells Reveals Key Importance of Glycolysis in Crescentic Glomerulonephritis

Session Information

Category: Glomerular Diseases

  • 1401 Glomerular Diseases: Mechanisms, including Podocyte Biology

Authors

  • Nies, Jasper Friedrich, Universitatsklinikum Koln Klinik II fur Innere Medizin Nephrologie Rheumatologie Diabetologie und Allgemeine Innere Medizin, Cologne, NRW, Germany
  • Sierra Gonzalez, Claudio, Universitatsklinikum Koln Klinik II fur Innere Medizin Nephrologie Rheumatologie Diabetologie und Allgemeine Innere Medizin, Cologne, NRW, Germany
  • Trinsch, Bastian, Universitatsklinikum Koln Klinik II fur Innere Medizin Nephrologie Rheumatologie Diabetologie und Allgemeine Innere Medizin, Cologne, NRW, Germany
  • Diefenhardt, Paul, Universitatsklinikum Koln Klinik II fur Innere Medizin Nephrologie Rheumatologie Diabetologie und Allgemeine Innere Medizin, Cologne, NRW, Germany
  • Eckey, Tobias, Universitatsklinikum Koln Klinik II fur Innere Medizin Nephrologie Rheumatologie Diabetologie und Allgemeine Innere Medizin, Cologne, NRW, Germany
  • Puetz, David L., Universitatsklinikum Koln Klinik II fur Innere Medizin Nephrologie Rheumatologie Diabetologie und Allgemeine Innere Medizin, Cologne, NRW, Germany
  • Schermer, Bernhard, Universitatsklinikum Koln Klinik II fur Innere Medizin Nephrologie Rheumatologie Diabetologie und Allgemeine Innere Medizin, Cologne, NRW, Germany
  • Benzing, Thomas, Universitatsklinikum Koln Klinik II fur Innere Medizin Nephrologie Rheumatologie Diabetologie und Allgemeine Innere Medizin, Cologne, NRW, Germany
  • Brinkkoetter, Paul T., Universitatsklinikum Koln Klinik II fur Innere Medizin Nephrologie Rheumatologie Diabetologie und Allgemeine Innere Medizin, Cologne, NRW, Germany
  • Braehler, Sebastian, Universitatsklinikum Koln Klinik II fur Innere Medizin Nephrologie Rheumatologie Diabetologie und Allgemeine Innere Medizin, Cologne, NRW, Germany
Background

Crescentic glomerulonephritis (cGN) is a severe, T cell-mediated autoimmune disorder with limited treatment options. The availability and use of various metabolites play a critical role in T cell activation and function. However, how oxidative phosphorylation and glycolysis influence T cell fate and behavior during cGN remains poorly understood, despite its central importance to disease pathogenesis. Understanding the metabolic pathways governing inflammatory T cell function may pave the way for novel therapeutic strategies.

Methods

To study T cell metabolism in autoimmune kidney disease, we employ the nephrotoxic nephritis (NTN) model. Given the low abundance of T cells in murine kidneys, we utilize single-cell approaches, including immunometabolic assays via flow cytometry (SCENITH) and analysis of human and murine single-cell RNA sequencing (scRNAseq) data. To assess the functional role of aerobic glycolysis in T cells, we use T cell-specific knockout mice for Ldha (a key enzyme in aerobic glycolysis) and characterized their CD4+ T cells under NTN and in vitro.

Results

Our results demonstrate that T cell activation in both humans and wild-type mice with cGN is characterized by a preferential reliance on aerobic glycolysis. Mice with a T cell-specific deletion of Ldha (CD4-Cre Ldhaflox; Ldha T-KO) develop significantly fewer glomerular crescents compared to controls. This is accompanied by a marked reduction in CD44+CD62L- effector CD4+ T cells and diminished Th1 polarization. In vitro, CD4+ T cells from Ldha T-KO mice exhibit significantly impaired proliferative capacity and increased susceptibility to cell death following CD3/CD28 stimulation. Longitudinal metabolomic analyses post-activation reveal that, due to impaired glycolytic flux, Ldha T-KO cells divert accumulating metabolites into the pentose phosphate pathway.

Conclusion

Kidney T cells rewire their metabolism in the NTN model by favoring glycolytic activity. Inhibition of aerobic glycolysis by genetic depletion in T cells reduced morphological kidney damage and strongly reduced effector and Th1 functions in CD4+ T cells. These findings could pave the way for a new therapeutic approach in T-cell driven kidney autoimmunity.

Funding

  • Government Support – Non-U.S.

Digital Object Identifier (DOI)